Site Master File
Site Master File
Site Master File
TABLE OF CONTENTS
Page
1. Document History ........................................................................................... 1
2. Introduction ..................................................................................................... 1
3. Purpose .......................................................................................................... 2
4. Scope ............................................................................................................. 2
5. Site Master File ............................................................................................... 2
6. Revision History .............................................................................................. 2
1. Document History
2. Introduction
2.1 The Site Master File is prepared by the cosmetic and/or Household Hazardous
Substance manufacturer and contains specific information about the quality
assurance, the production and/or quality control of HHS manufacturing
operations carried out at the named site and any closely integrated operations at
adjacent and nearby buildings. If only part of a HHS operation is carried out on
the site, a Site Master File need only describe those operations, e.g. analysis,
packaging, etc.
2.2 When submitted to Food and Drug Administration (FDA), the Site Master File
provides information on the manufacturer’s operations and procedures that can
be useful in the efficient planning and undertaking of a GMP inspection.
1
ANNEX B: Site Master File Cosmetics/HHS
2.3 These guidance notes have been set out in such a manner that each chapter and
the paragraphs noted under "REQUIREMENT" is followed by "GUIDANCE" to
provide details of how the requirements should be interpreted.
2.4 A Site Master File should be succinct and, as far as possible, not exceed
approximately twenty-five to thirty A4 pages.
2.5 The Site Master File should have an edition number and an effective date. The
format and headings should follow those given in documentation systems of the
company.
2.6 Wherever possible, simple plans, outline drawings or schematic layouts should
be used instead of narrative. These plans etc should fit on A4 sheets of paper. A
deliberate limit has been set on the length of the narrative. If more detailed
information is required, then this will be taken up by the Inspector in his/her part
of the report.
3. Purpose
The aim of these Explanatory Notes is to guide the manufacturer of HHS products in the
preparation of a Site Master File that can be useful to the regulatory authority in planning
and conducting GMP inspections.
4. Scope
These Explanatory Notes apply to the preparation of the Site Master File.
6. Revision History
Version
Date Reason for revision
number
2
ANNEX B: Site Master File Cosmetics/HHS
REQUIREMENT
C.1.1 Brief information on the firm (including name and address), relation to
other sites and, particularly, any information relevant to understand the
manufacturing operations.
GUIDANCE
C.1.1 In not more than 250 words (one A4 page) outline the firm's activities, other
sites, in addition to the site which is the subject of this report.
REQUIREMENT
NRA.
GUIDANCE
C.1.2 Quote the relevant document as issued by FDA. State period of validity of
licence document (if the validity of the document is given in the country
concerned). Any conditions and/or restrictions should be stated.
REQUIREMENT
GUIDANCE
C.1.3 This covers both cosmetic products, HHS products and other health product
(e.g. food and devices) activities.
3
ANNEX B: Site Master File Cosmetics/HHS
REQUIREMENT
C.1.4 Name and exact address of the site, including telephone, fax and 24 hrs
telephone numbers.
GUIDANCE
REQUIREMENT
C.1.5 Type of actual products manufactured on the site (see list at Appendix),
and information about specifically toxic or hazardous substances
handled, mentioning the way they are manufactured (in dedicated facilities
or on a campaign basis).
GUIDANCE
REQUIREMENT
C.1.6 Short description of the site (size. location and immediate environment
and other manufacturing activities on the site).
GUIDANCE
REQUIREMENT
GUIDANCE
C.1.7 (Note: Include employees working only part-time on full-time equivalent basis.
Give the rate of the academic and non-academic persons.)
REQUIREMENT
GUIDANCE
5
ANNEX B: Site Master File Cosmetics/HHS
REQUIREMENT
GUIDANCE
REQUIREMENT
C.2 PERSONNEL
6
ANNEX B: Site Master File Cosmetics/HHS
C.2.3.3 State the form of training e.g. in-house, external, and how
practical experience is gained and which staff are involved.
C.2.3.4 Explain how the efficacy of the training is assessed e.g. by
questionnaires.
C.2.3.5 Explain how retraining needs are identified.
C.2.3.6 Give brief details of records kept.
GUIDANCE
C.2.3 Outline of Arrangements for Basic and In-service Training and how Records are
maintained
Give brief details of the training programme and include induction and
continuous training, as follows:
7
ANNEX B: Site Master File Cosmetics/HHS
REQUIREMENT
Premises
Equipment
Sanitation
8
ANNEX B: Site Master File Cosmetics/HHS
GUIDANCE
C.3.1 Premises
C.3.2.1 To reduce narrative for a large complex plant, the details should be
limited to critical areas.
C.3.2.2 These areas must include all processing and packaging and critical
storage areas.
C.3.2.3 A narrative format is preferred.
Note 1: More details should be given for critical areas with potential risks of airborne
contamination. This will include areas for processing powder and wet cosmetic
and/or HHS products
9
ANNEX B: Site Master File Cosmetics/HHS
C.3.4 Special Areas for the Handling of Highly Toxic Hazardous Materials
Note: Schematic drawings of the systems are preferred. The following information
must appear:
Note: For the purpose of this guide "Maintenance" is carried out by the manufacturer
and "servicing" by an outside contractor.
C.3.6.2 Are there written procedures and suitable reporting forms for
maintenance and servicing? Do the documents record type frequency
of services/checks, details of service, repairs and modifications?
10
ANNEX B: Site Master File Cosmetics/HHS
C.3.6.3 Are the maintenance routines that could affect product quality clearly
identified?
C.3.6.4 Are the reports made known to the users?
Note: Makes and model numbers equipment are not required. However the following
points should be addressed:
11
ANNEX B: Site Master File Cosmetics/HHS
C.3.9.1 Briefly describe the Company's general policy and protocols for
qualification
C.3.9.2 Is there regular qualification of critical equipment?
C.3.9.3 Describe the system for the release for sale
C.3.9.4 Describe equipment calibration policy and records kept. (See also
para 4.2.9)
C.3.10 Sanitation
REQUIREMENT
C.4 DOCUMENTATION
GUIDANCE
12
ANNEX B: Site Master File Cosmetics/HHS
13
ANNEX B: Site Master File Cosmetics/HHS
REQUIREMENT
C.5 PRODUCTION
GUIDANCE
C.5 PRODUCTION
C.5.1 Describe the operations capable of being carried out at the site with the
existing facilities and specify the types of cosmetics and /or HHS products
products. (See para 1.5.1 and the Appendix for types of products
manufactured).
C.5.2 Arrangements for handling Starting Materials, Packing Materials, Bulk and
Finished Products including Sampling Quarantine Release and Storage
14
ANNEX B: Site Master File Cosmetics/HHS
C.5.2.2 Packing
C.5.4.1 Are reject materials and products clearly labelled? Are they stored
separately in restricted areas?
C.5.4.2 Describe arrangements for sentencing the materials and their
disposal. Is destruction recorded?
15
ANNEX B: Site Master File Cosmetics/HHS
REQUIREMENT
GUIDANCE
REQUIREMENT
GUIDANCE
C.7.1 Describe briefly the details of the technical contract between the
contract giver and acceptor and the way in which the GMP
compliance is assessed to ensure product compliance to
notification.
16
ANNEX B: Site Master File Cosmetics/HHS
REQUIREMENT
GUIDANCE
C.8 DISTRIBUTION
Do the retained records permit full batch traceability from the factory
to the customer, in terms of the date of sale, customer details and
quantity despatched?
C.8.2.1 Complaints
REQUIREMENT
GUIDANCE
C.9.1.1 Describe how the IQA system verifies that those activities that have
a bearing on quality comply with the planned arrangement.
C.9.1.2 Are the quality systems effective?
C.9.1.3 Are there documented procedures for the IQA system and for the
follow-up actions?
C.9.1.4 Are the results of the IQA system documented, brought to the
attention of the personnel having responsibility for the area and
activities inspected?
C.9.1.5 Does the system ensure that those responsible for the area or
activity take timely corrective action on the deficiencies found?
18